Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline - Wikidata - wikimedia - TriplyDB

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

http://www.wikidata.org/entity/Q27022596

about

The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications.Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?Effect of HIV on liver fibrosis among HCV-infected African Americans Serious Non-AIDS events: Immunopathogenesis and interventional strategies.HCV enters the twenty-first century.Detecting spatial clusters of HIV and hepatitis coinfections

P2860

Q30061914-6683F2A6-CBD1-4B55-8DC4-D8F75520A5F2 Q34806261-2FB3BB86-9BA1-4B5D-AEFD-939CD6549F24 Q35860136-FE7ADC2B-2786-4187-9A5F-AC5E2A7E2121 Q36853890-C9A045B8-9220-4FE9-B90B-61B87E359226 Q37418140-63DC50EC-5939-4C9D-A8E9-D12037600ED8 Q42281701-440699CB-EFA8-44CB-A7F1-AFD4D8FBECF5 Q58727324-EEDF5062-81EF-4889-B27A-96126D44216E

P2860

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

http://www.wikidata.org/entity/Q27022596

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@ast

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@en

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@nl

type

label

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@ast

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@en

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@nl

prefLabel

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@ast

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@en

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@nl

P1433

Q27022596-A7E475EB-AB66-4FFB-9A59-A44CECCF522F

P1476

Q27022596-9F4F1653-8755-4CFF-8673-440D9DB79778

P2093

Q27022596-B351CFA6-2202-4426-A13A-DCB21AE8A339

Q27022596-C2B459DE-418D-425E-AD70-D745731AA801

P2860

Q27022596-0A19AFA0-B04E-4DA0-8512-41045CE4B4BA

Q27022596-1B491908-71A6-43A4-B35E-3FB40AF59322

Q27022596-1D04C18B-65E7-4E21-96A8-C500019BC548

Q27022596-23EE6D7F-7090-427E-82E7-7167F1828E74

Q27022596-2A0F00B5-78C7-4B5C-80A5-0E550F5034C2

Q27022596-2BED16E0-F894-4241-A662-01DE2BDFD7DB

Q27022596-2EBB0C0A-507D-4323-A0E8-C9E9397E32ED

Q27022596-3E72E6E7-17AA-49D9-ACC1-1762B9147B38

Q27022596-48816A10-F233-4A01-BD32-9FB5EBF45375

Q27022596-605170BB-974A-4A34-A761-2B8162934B40

P2888

Q27022596-ED004B4D-2C9B-4A37-8196-535A70CE5FD3

P304

Q27022596-EB0DECA8-535D-4001-8289-6DFBC0ACD9E2

P31

Q27022596-8E13F408-CC31-42DB-A78C-4B9D530D54BC

P356

Q27022596-C2247748-7910-4F42-B412-EBA8348B8E73

P407

Q27022596-226C7860-FA9E-462D-B8AF-87988798E289

P433

Q27022596-774B7C3D-7FB0-4FA4-A6EC-A52DA4753E21

P478

Q27022596-DDC8CDAE-499C-4DF4-A684-21670F6AD9BC

P577

Q27022596-ACE28097-EAB3-4F13-8000-3835D63BB67A

P6179

Q27022596-C49DF001-1AAA-463F-845A-24467286585D

P698

Q27022596-C7E2FCD9-410D-4023-97FA-A4215A8397D3

P921

Q27022596-892B3119-2CDA-4A5E-AAE1-5EC99575D739

P932

Q27022596-94597242-8908-46C7-B903-11C305F5A9F4

P356

S11904-012-0122-Z

P1433

Current HIV/AIDS reports

P1476

Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline

@en

P2093

Carrie L. Jennings

http://www.w3.org/2001/XMLSchema#string

Kenneth E. Sherman

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Boceprevir for previously treated chronic HCV genotype 1 infection

Review and management of drug interactions with boceprevir and telaprevir

A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Human immunodeficiency virus and liver disease forum 2010: conference proceedings

Telaprevir for retreatment of HCV infection

Telaprevir for previously untreated chronic hepatitis C virus infection

P2888

s11904-012-0122-z

P304

231-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11904-012-0122-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033706414

http://www.w3.org/2001/XMLSchema#string

P698

22638982

http://www.w3.org/2001/XMLSchema#string

P921

P932

3551247

http://www.w3.org/2001/XMLSchema#string